Nestle signs deal to study effect of food on human cells

Cellular Dynamics International (CDI) has signed a deal to supply the Nestle Institute of Health Sciences (NSRGF) with stem cells that the Swiss company will use to study the effect that food nutrients have on human cells.

Specifically, Nestle will obtain brain and liver cells as part of a plan to develop nutritionally enhanced drinks, smoothies and other products that the food giant can market as having medical benefits.

The deal follows Nestle's purchase last year of Pamlab, a maker of "medical foods." (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs